CT
Therapeutic Areas
Collegium Pharmaceutical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| XTAMPZA ER | Severe pain | Marketed |
| NUCYNTА / NUCIENTА ER | Severe pain | Marketed |
| BELBUCA | Severe pain | Marketed |
| JORNAY PM | ADHD | Marketed |
| AZSTARYS | ADHD | Acquisition Pending |
Leadership Team at Collegium Pharmaceutical
VK
Vikram Karnani
President & Chief Executive Officer
TS
Thomas Smith, M.D.
Executive Vice President, Chief Medical Officer
SD
Scott Dreyer
Executive Vice President, Chief Commercial Officer
JG
Jane Gonnerman
Executive Vice President, Strategy & Corporate Development
DD
David Dieter
Executive Vice President, General Counsel
SS
Scott Sudduth
Executive Vice President, Head of Technical Operations
DJ
Dean J. Patras
Chief People Officer
GS
Gino Santini
Chairman of the Board